Home
Patient Center
Clinical Trial
About Us
Chairman’s Message
Our Company
Leadership
Research&Development
Areas of Focus
Pipeline
Newsroom
Company News
Guidelines&Recomandations
Publications
Contact Us
Contacts
Human Resources
中文
English
中文
English
Home
Patient Center
Clinical Trial
About Us
Chairman’s Message
Our Company
Leadership
Research&Development
Areas of Focus
Pipeline
Newsroom
Company News
Guidelines&Recomandations
Publications
Contact Us
Contacts
Human Resources
Learn More
Investigator Meeting for the Pediatric Phase III Clinical Trial of the First Domestic Long-Acting Recombinant Coagulation Factor VIII Product (FRSW107) Successfully Held in Quanzhou, Fujian
2023-10-25
Learn More
Gensciences: First Subject Enrolled in Phase Ib/II Clinical Trial of the First Domestic Long-Acting Recombinant Activated Factor VII Product (SS109)
2023-10-13
Learn More
Clinical Data of the Heavyweight Innovative Drug Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (SS327) Developed by Gensciences Presented at 2023 ISTH
2023-06-27
Learn More
More News
Research&Development
Learn More
Areas of Focus
Pipeline